The Phase I Clinical Trial Units provide a vehicle for the investigation of new therapeutic and immunomodulatory agents for the treatment of infectious disease.
IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
-
Activity
N01
-
Administering IC
AI
-
Application Type
-
Direct Cost Amount
-
Indirect Cost Amount
-
Total Cost
99299
-
Sub Project Total Cost
-
ARRA Funded
False
-
CFDA Code
-
Ed Inst. Type
-
Funding ICs
NIAID:99299\
-
Funding Mechanism
Non SBIR/STTR Contracts
-
Study Section
-
Study Section Name